Smartleaf Asset Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Smartleaf Asset Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54K	Hold	27	–	–	﹤0.01%	3012
2026 Q1	$1.12K	Sell	27 -9	-25%	-$416	﹤0.01%	3099
2025 Q4	$1.64K	Sell	36 -4,852	-99%	-$215K	﹤0.01%	3042
2025 Q3	$187K	Buy	4,888 +1	+0%	+$36	0.01%	758
2025 Q2	$164K	Buy	4,887 +1,154	+31%	+$36.5K	0.01%	648
2025 Q1	$125K	Buy	3,733 +582	+18%	+$22.1K	0.01%	744
2024 Q4	$122K	Buy	3,151 +316	+11%	+$13.3K	0.01%	750
2024 Q3	$126K	Buy	2,835 +59	+2%	+$2.64K	0.02%	637
2024 Q2	$117K	Sell	2,776 -34	-1%	-$1.42K	0.02%	530
2024 Q1	$128K	Buy	2,810 +109	+4%	+$4.96K	0.02%	463
2023 Q4	$127K	Buy	+2,701	New	+$110K	0.03%	387

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Smartleaf Asset Management's GNOM Position: Q2 2026 in Review

Smartleaf Asset Management held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 27 shares worth $1.54K. The position accounts for ﹤0.01% of the portfolio, ranked #3012.

Smartleaf Asset Management first reported a position in GNOM in Q4 2023 and has held it in 11 quarters since. The position peaked at $187K in Q3 2025. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Smartleaf Asset Management held 27 shares of Global X Genomics & Biotechnology ETF worth $1.54K as of Q2 2026.
Smartleaf Asset Management left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3012 holding.
Smartleaf Asset Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's Global X Genomics & Biotechnology ETF position peaked at $187K in Q3 2025.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.